Literature DB >> 15060420

The endogenous thrombin potential and high levels of coagulation factor VIII, factor IX and factor XI.

Annelie Siegemund1, Sirak Petros, Thomas Siegemund, Ute Scholz, Hans-Jürgen Seyfarth, Lothar Engelmann.   

Abstract

High plasma concentrations of factor VIII, factor IX and factor XI have been reported as thrombosis risk factors. Using the thrombin generation test in platelet-poor plasma, it was aimed to describe the mechanism for this increased thrombosis risk. Endogenous thrombin potential was measured in platelet-poor plasma in 180 patients with a history of thromboembolism, and results were compared with those of 180 age-matched and sex-matched controls. Subjects with major hereditary and acquired thrombophilia were excluded. Plasma concentrations of the clotting factor VIII, factor IX and factor XI were significantly elevated in patients compared with controls. The mean endogenous thrombin potential was significantly higher in patients than in controls: 191.3 +/- 3.1 (95% confidence interval, 185.3-197.4) arbitrary units versus 180.8 +/- 2.6 (95% confidence interval, 175.7-185.9) arbitrary units (P = 0.009). The endogenous thrombin potential was significantly higher in patients with elevated factor IX and factor XI, but elevated factor VIII was not associated with a significant increase in endogenous thrombin potential. In conclusion, the increased thrombosis risk associated with high plasma concentrations of factor IX and factor XI may be explained by the increase in endogenous thrombin potential. However, this did not help explain the association between elevated factor VIII and thrombosis risk.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15060420     DOI: 10.1097/00001721-200404000-00007

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  8 in total

1.  Active tissue factor and activated factor XI in circulating blood of patients with systolic heart failure due to ischemic cardiomyopathy.

Authors:  Michał Zabczyk; Saulius Butenas; Ilona Palka; Jadwiga Nessler; Anetta Undas
Journal:  Pol Arch Med Wewn       Date:  2010-09

2.  Correlation between factor (F)XIa, FIXa and tissue factor and trauma severity.

Authors:  Shannon M Prior; Mitchell J Cohen; Amanda S Conroy; Mary F Nelson; Lucy Z Kornblith; Benjamin M Howard; Saulius Butenas
Journal:  J Trauma Acute Care Surg       Date:  2017-06       Impact factor: 3.313

3.  Effects of tissue factor, thrombomodulin and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram.

Authors:  Kellie R Machlus; Emily A Colby; Jogin R Wu; Gary G Koch; Nigel S Key; Alisa S Wolberg
Journal:  Thromb Haemost       Date:  2009-11       Impact factor: 5.249

4.  Blood hypomethylation of inflammatory genes mediates the effects of metal-rich airborne pollutants on blood coagulation.

Authors:  Letizia Tarantini; Matteo Bonzini; Armando Tripodi; Laura Angelici; Francesco Nordio; Laura Cantone; Pietro Apostoli; Pier Alberto Bertazzi; Andrea A Baccarelli
Journal:  Occup Environ Med       Date:  2013-03-08       Impact factor: 4.402

5.  Effects of inhalable particulate matter on blood coagulation.

Authors:  M Bonzini; A Tripodi; A Artoni; L Tarantini; B Marinelli; P A Bertazzi; P Apostoli; A Baccarelli
Journal:  J Thromb Haemost       Date:  2009-11-17       Impact factor: 5.824

6.  Extracellular histones mediate the effects of metal-rich air particles on blood coagulation.

Authors:  L Cantone; L Angelici; V Bollati; M Bonzini; P Apostoli; A Tripodi; P A Bertazzi; A A Baccarelli
Journal:  Environ Res       Date:  2014-04-16       Impact factor: 6.498

Review 7.  The heart as an extravascular target of endothelin-1 in particulate matter-induced cardiac dysfunction.

Authors:  Elizabeth A W Chan; Barbara Buckley; Aimen K Farraj; Leslie C Thompson
Journal:  Pharmacol Ther       Date:  2016-05-21       Impact factor: 12.310

8.  Activation of blood coagulation and thrombin generation in acute ischemic stroke treated with rtPA.

Authors:  Sarah Goldman; Shannon M Prior; Jan P Bembenek; Maciej Niewada; Elżbieta Broniatowska; Anna Członkowska; Saulius Butenas; Anetta Undas
Journal:  J Thromb Thrombolysis       Date:  2017-10       Impact factor: 2.300

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.